VM
PDSB icon

VHCP Management’s PDS Biotechnology PDSB Stock Holding History

VHCP Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.69M Hold
6,750
– – 1.82% 13
2016
Q3 		$1.41M Hold
6,750
– – 1.38% 17
2016
Q2 		$1.36M Hold
6,750
– – 1.41% 15
2016
Q1 		$1.24M Hold
6,750
– – 1.07% 18
2015
Q4 		$1.69M Buy
+6,750
New +$2.18M 1.02% 16

Other funds holding PDSB

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VHCP Management's PDSB Position: Q4 2016 in Review

VHCP Management held its PDS Biotechnology (PDSB) position steady in Q4 2016 at 6,750 shares worth $1.69M. The position accounts for 1.82% of the portfolio, ranked #13.

VHCP Management first reported a position in PDSB in Q4 2015 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2016.

  • VHCP Management held 6,750 shares of PDS Biotechnology worth $1.69M as of Q4 2016.
  • VHCP Management left its PDS Biotechnology share count unchanged in Q4 2016.
  • PDS Biotechnology made up 1.82% of VHCP Management's portfolio in Q4 2016, its #13 holding.
  • VHCP Management first reported a position in PDS Biotechnology in Q4 2015 and has held it in 5 quarters since.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.